Now I have a clear picture. Let me write the final consolidated review.

## Summary
This paper introduces the problem of PPI candidate ranking — prioritizing potential interaction partners for experimental validation — and proposes a framework that leverages known interactors as anchors, applies interpretability-guided active-region selection from predicted contact maps to compute embedding cosine similarities, and then re-ranks top candidates using multi-source biological and semantic signals. The framework is evaluated prospectively on STRING v11→v12 transitions against raw interaction probability baselines from D-SCRIPT, Topsy-Turvy, and xCAPT5, showing substantial improvements in early ranking metrics (e.g., Recall@10 rising from 0.0124 to 0.2641 for D-SCRIPT).

## Strengths
1. **Novel problem formulation with prospective evaluation design**: The paper formally defines PPI candidate ranking (Equations 1–2) and constructs a prospective test bed using successive STRING releases (v11→v12), directly addressing the limitation that existing PPI models are typically evaluated on static retrospective benchmarks. This setup asks whether computational methods can anticipate interactions not yet experimentally confirmed, which is practically meaningful.

2. **Clear empirical improvements over raw model scores**: Table 1 shows that the overall framework (interpretability-guided retrieval + known-interactor anchoring) dramatically improves over direct interaction probabilities from D-SCRIPT, Topsy-Turvy, and xCAPT5. For D-SCRIPT, Recall@10 rises from 0.0124 to 0.2641, MRR from 0.0340 to 0.1685, and Success@10 from 0.0040 to 0.1277. These are practically meaningful gains for candidate screening.

3. **Comprehensive multi-source re-ranking analysis**: The re-ranking module (Section 4.2) integrates 10 complementary signals (interaction scores, pDockQ, TF-IDF, Jaccard overlaps on tokens/locations/keyterms, three LLM-based scores). The pairwise rank-shift analysis in Table 2 systematically quantifies complementarity — PubMedBERT improves or maintains 75.5% of rediscoveries versus the cosine baseline, while pDockQ underperforms at early ranking (47.2%). This provides actionable guidance for practitioners.

4. **Rigorous leakage control in LLM fine-tuning**: The cross-encoder PubMedBERT re-ranker uses GroupKFold split by protein identity (Section 4.2), ensuring no protein appears in both training and validation sets — a careful design that avoids protein-level leakage.

## Weaknesses

### Fatal
None.

### Major
1. **Missing ablation for the core claimed mechanism — active-region selection is never isolated**. The paper's central methodological claim is that *interpretability-guided retrieval via active embedding regions* improves candidate ranking. However, the method simultaneously introduces (i) using known interactors as anchors (information the baselines cannot access), (ii) cosine similarity over embeddings rather than the model's final interaction score, and (iii) active-region cropping from contact maps. The only baseline against this stage is the raw interaction probability (IS), which does not use known interactors at all. An ablation ranking candidates by cosine similarity between *full* (non-cropped) embeddings of each known interactor and the candidate's embedding would directly test whether the active-region step adds value beyond simply using known interactors with embedding similarity. Without this, the reported improvements (e.g., Recall@5 from 0.007 to 0.183) could largely reflect the trivial fact that known interactors carry useful information — a point the authors themselves acknowledge ("the underlying idea is that novel interactions of a target protein should follow similar mechanisms to already observed interactions"). This is a structural gap: the paper cannot cleanly support its claimed contribution in the current form.

2. **The "two orders of magnitude" claim is numerically inaccurate**. The abstract and conclusions state the framework "improves ranking metrics by two orders of magnitude." In Table 1, the largest ratio at early cutoffs is Recall@5 for D-SCRIPT: 0.0071 → 0.1832 (≈26×, not 100×). MRR improves 0.0340 → 0.1685 (≈5×), and MAP@10 improves 0.0133 → 0.2952 (≈22×). None approach two orders of magnitude. This overstatement appears in the paper's strongest claims (abstract, introduction, conclusions) and misrepresents the scale of improvement.

### Minor
3. **Re-ranking analysis reports rank-shifts but not final retrieval quality**. Table 2 measures whether rediscovered interactions maintain or improve their rank position when switching between re-ranking signals. However, re-ranking is applied only to the top-10 candidates from Stage 1, so the total set of relevant items discovered is fixed. The analysis does not report whether re-ranking actually improves practical screening metrics (Recall@k, Success@k after re-ranking). A signal could "improve" ranks for some true partners while worsening others, and the net effect on overall retrieval quality is unclear.

4. **Active-region selection assumes a single contiguous binding interface without justification**. The method selects "the contiguous set of residues with the highest average activation score" (Section 4.1). Many PPIs involve multiple discontinuous binding patches. The paper offers no analysis or sensitivity study for this design choice — e.g., testing multiple segments, threshold-based selection, or varying quantiles. The robustness of this assumption is unexamined.

5. **No analysis of how the number of known interactors affects performance**. The method's reliance on known partners (KP(p)) as anchors means proteins with few known interactors will have less anchor signal. While acknowledged in Section 6 as a limitation, no diagnostic results (e.g., performance stratified by |KP(p)|) are provided to quantify degradation.

### Trivial
None.

## Nice-to-Haves
- Adding a baseline ranking by cosine similarity between the *target's own* embedding and each candidate (no anchors), to further isolate the effect of using known interactors.
- Reporting the final retrieval metrics (Recall@k, Success@k) after PubMedBERT re-ranking to demonstrate practical screening improvement.
- Including bootstrapped confidence intervals for the metrics in Tables 1 and 2.
- Sensitivity analysis for the active-region selection (e.g., multiple segments, threshold-based selection).

## Removed Points
- **Criticism about xCAPT5 "Prediction Coverage" being unclear**: The paper reports Prediction Coverage in Table 1, and the concept is explained in Section 5.2 ("Total number of true novel partners that are successfully retrieved across all proteins"). The numerical difference (0.8088 vs. >0.92) is transparently presented — the paper does not claim fairness in coverage, it reports the metric.
- **Criticism about sliding-window cosine similarity being computationally heavy**: This is acknowledged in Section 5.3 ("retrieval remains the computational bottleneck, with runtimes in the order of hundreds of hours"). The criticism adds nothing the paper doesn't already say.
- **Criticism about "baseline numbers are very low... which seems inconsistent with reported interaction probabilities"**: This is speculative — the paper is evaluated on a prospective setting (STRING v12 interactions not seen by models), so low baselines are expected and indeed motivate the proposed approach. No evidence is presented that scores are "poorly calibrated."
- **Criticism about Table 2 formatting (symbols "not visible")**: This is a parser artifact, not a paper problem.
- **Criticism about "missing appendix" / "cannot assess reproducibility"**: The appendix was stripped by the parser. This is not a valid criticism of the paper as submitted.
- **Strength Finder's endorsement of "two orders of magnitude" claim**: This strength is factually wrong — the numbers do not support two orders of magnitude — and is removed as it conflicts with verified weakness #2.

## Novel Insights
None beyond the paper's own contributions.

## Suggestions
1. **Add the critical ablation**: Rank candidates by cosine similarity between *full* (non-cropped) embedding of each known interactor and the candidate's embedding. Compare this directly to the interpretability-guided (active-region) version. If the improvement from the active-region version over the full-embedding version is large, the mechanism is validated; if small, the paper's contribution reduces to "use known interactors." Both outcomes are informative.
2. **Correct the "two orders of magnitude" claim**: Replace with precise language (e.g., "improving early ranking metrics by up to 26× at Recall@5, and 4–6× on MRR").
3. **Report final retrieval metrics after re-ranking**: Show Recall@k, Success@k, and MRR for the best re-ranking signal (PubMedBERT) vs. Stage 1 output to demonstrate that re-ranking actually improves practical screening.
4. **Analyze performance stratified by known-partner count**: Show how metrics degrade when |KP(p)| is small.

## Score and Decision

**Round 1 bracket**: After reading the paper and verifying reviewer claims against the paper text, I initially bracketed between 5.0 and 7.0. Weak anchors (avg ≤ 3.0) were from papers with fundamental flaws. Strong anchors (avg ≥ 8.0) were from papers with outstanding contributions beyond this paper's level. Middle anchors (avg 5.0–6.0) included comparable PPI/bioinformatics papers.

**Round 2 narrowing**: I read five anchor papers in full:
- **MAPE-PPI (avg 5.67, Accept)**: Novel PPI prediction method with embedding learning. Similar domain, similar score range. MAPE-PPI had notable weaknesses (novelty concerns, missing baselines) but was accepted. The current paper has a more novel task formulation but a more central evaluation gap (missing ablation for core mechanism). Comparable quality; if anything, slightly weaker due to the evaluation gap.
- **LLaPA (avg 6.0, Reject)**: Multimodal LLM for PPI. Had clearer writing but significant concerns about LLM necessity and unfair comparisons. The current paper has a more rigorous prospective evaluation design, making it slightly stronger overall.
- **Protein Function Prediction / ProtIR (avg 5.25, Reject)**: Retrieval-based function prediction. Had issues with missing baselines and unclear methodology. The current paper is stronger — clearer contribution and more rigorous evaluation.
- **PEEP (avg 5.6, Reject)**: Enzyme function prediction. Limited novelty concerns. The current paper has a more novel task formulation.
- **Bioactivity Prediction (avg 7.0, Accept)**: Dataset + evaluation paradigm paper. Well-executed but a different kind of contribution. The current paper has a narrower evaluation gap issue that prevents it from reaching this level.

**Final score determination**: Relative to these anchors, the paper sits near MAPE-PPI (5.67) but with a more central evaluation gap that makes it slightly weaker. It is stronger than ProtIR (5.25). The most appropriate position is **5.5**. The paper has a genuine contribution (novel task, prospective evaluation design, clear empirical improvements) but the missing ablation for the core claimed mechanism prevents it from being accepted as-is. A major revision adding the ablation and correcting the overstated claims would strengthen it substantially.

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Reject</decision>